Literature DB >> 1532250

Acute hepatic failure associated with oral minocycline: a case report.

D I Min1, P A Burke, W D Lewis, R L Jenkins.   

Abstract

A 39-year-old woman was evaluated for possible liver transplantation due to rapidly developing hepatic failure 4 weeks after initiation of oral minocycline 100 mg twice a day for the treatment of acne. The patient developed a maculopapular rash, malaise, fever, nausea, and vomiting 2 weeks prior to admission to the hospital. On admission, her symptoms rapidly progressed to liver failure characterized by rapidly rising liver enzyme levels, worsening encephalopathy, and coagulopathy. Viral hepatitis serologies and blood cultures were all negative. After intensive supportive care for 2 weeks, the patient's condition gradually improved and she was discharged with mildly elevated liver enzyme levels and pruritus, without need of liver transplantation. Minocycline-induced hepatic injury is an idiosyncratic reaction with a sensitization period that appears to be 3-4 weeks in duration. The characteristic features include rash, fever, lymphadenopathy, and eosinophilia, as well as severe alterations in liver function. The high liver enzyme levels and the significant prolongation of the prothrombin time suggest massive hepatocellular damage. In light of the profound liver damage that occurs with this adverse reaction, care should be taken in administering minocycline to patients who have concomitant liver disease. It is recommended that patients should be instructed as to the possible signs and symptoms of toxicity and be monitored for evidence of idiosyncratic reaction or liver failure.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1532250

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  8 in total

Review 1.  Benefits and risks of minocycline in rheumatoid arthritis.

Authors:  P Langevitz; A Livneh; I Bank; M Pras
Journal:  Drug Saf       Date:  2000-05       Impact factor: 5.606

2.  Minocycline toxicity requiring liver transplant.

Authors:  Julian E Losanoff; Jennifer M Holder-Murray; Emily B Ahmed; Adam B Cochrane; Giuliano Testa; J Michael Millis
Journal:  Dig Dis Sci       Date:  2007-04-03       Impact factor: 3.199

3.  Liver damage associated with minocycline use in acne: a systematic review of the published literature and pharmacovigilance data.

Authors:  R A Lawrenson; H E Seaman; A Sundström; T J Williams; R D Farmer
Journal:  Drug Saf       Date:  2000-10       Impact factor: 5.606

4.  Study of immune reactivity of minocycline-induced chronic active hepatitis.

Authors:  D Herzog; O Hajoui; P Russo; F Alvarez
Journal:  Dig Dis Sci       Date:  1997-05       Impact factor: 3.487

5.  Minocycline induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome.

Authors:  A Gough; S Chapman; K Wagstaff; P Emery; E Elias
Journal:  BMJ       Date:  1996-01-20

6.  [Cutaneous xanthomas associated with minocycline-induced cholestatic jaundice].

Authors:  C Bamberg; J Laskowski; R Zimmermann; G Gross
Journal:  Hautarzt       Date:  2003-09       Impact factor: 1.198

7.  Pseudomembranous Invasive Tracheobronchial Aspergillosis with Fulminant Hepatitis and Hemophagocytic Syndrome.

Authors:  Suguru Majima; Shotaro Okachi; Motoyo Asano; Keiko Wakahara; Naozumi Hashimoto; Mitsuo Sato; Masatoshi Ishigami; Yoshinori Hasegawa
Journal:  Intern Med       Date:  2018-03-30       Impact factor: 1.271

8.  An electronic medical records-based approach to identify idiosyncratic drug-induced liver injury in children.

Authors:  Tracy L Sandritter; Jennifer L Goldman; Clayton J Habiger; James F Daniel; Jennifer Lowry; Ryan T Fischer
Journal:  Sci Rep       Date:  2019-12-02       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.